Kamran Alam

Chief Financial Officer, Taysha Gene Therapies, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.5M

Companies

Latest trade

Feb 4, 2026

Companies

Taysha Gene Therapies, Inc.Chief Financial Officer −$0.5M

Trades

TSHA Sold 1,655 shares at $4.52 $0.0M Feb 4

TSHA Sold 23,849 shares at $4.61 $0.1M Jan 26

TSHA Sold 78,968 shares at $4.75 $0.4M Jan 23

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.